BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 9864090)

  • 21. Elevated frequencies of benzo(a)pyrene-induced Hprt mutations in internal tissue of XPA-deficient mice.
    Bol SA; van Steeg H; Jansen JG; Van Oostrom C; de Vries A; de Groot AJ; Tates AD; Vrieling H; van Zeeland AA; Mullenders LH
    Cancer Res; 1998 Jul; 58(13):2850-6. PubMed ID: 9661901
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Importance of DNA repair in carcinogenesis: evidence from transgenic and gene targeting studies.
    Ishikawa T; Ide F; Qin X; Zhang S; Takahashi Y; Sekiguchi M; Tanaka K; Nakatsuru Y
    Mutat Res; 2001 Jun; 477(1-2):41-9. PubMed ID: 11376685
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Finding transcriptomics biomarkers for in vivo identification of (non-)genotoxic carcinogens using wild-type and Xpa/p53 mutant mouse models.
    Jonker MJ; Bruning O; van Iterson M; Schaap MM; van der Hoeven TV; Vrieling H; Beems RB; de Vries A; van Steeg H; Breit TM; Luijten M
    Carcinogenesis; 2009 Oct; 30(10):1805-12. PubMed ID: 19696161
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Detection of genotoxic and non-genotoxic carcinogens in Xpc(-/-)p53(+/-) mice.
    Melis JP; Speksnijder EN; Kuiper RV; Salvatori DC; Schaap MM; Maas S; Robinson J; Verhoef A; van Benthem J; Luijten M; van Steeg H
    Toxicol Appl Pharmacol; 2013 Jan; 266(2):289-97. PubMed ID: 23153559
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A perspective on current and future uses of alternative models for carcinogenicity testing.
    Goodman JI
    Toxicol Pathol; 2001; 29 Suppl():173-6. PubMed ID: 11695554
    [TBL] [Abstract][Full Text] [Related]  

  • 26. XPA gene-deficient, SCF-transgenic mice with epidermal melanin are resistant to UV-induced carcinogenesis.
    Yamazaki F; Okamoto H; Miyauchi-Hashimoto H; Matsumura Y; Itoh T; Tanaka K; Kunisada T; Horio T
    J Invest Dermatol; 2004 Jul; 123(1):220-8. PubMed ID: 15191564
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Assessment of carcinogenicity of di(2-ethylhexyl)phthalate in a short-term assay using Xpa-/- and Xpa-/-/p53+/- mice.
    Mortensen A; Bertram M; Aarup V; Sørensen IK
    Toxicol Pathol; 2002; 30(2):188-99. PubMed ID: 11950162
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mouse model for the DNA repair/basal transcription disorder trichothiodystrophy reveals cancer predisposition.
    de Boer J; van Steeg H; Berg RJ; Garssen J; de Wit J; van Oostrum CT; Beems RB; van der Horst GT; van Kreijl CF; de Gruijl FR; Bootsma D; Hoeijmakers JH; Weeda G
    Cancer Res; 1999 Jul; 59(14):3489-94. PubMed ID: 10416615
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mouse models for xeroderma pigmentosum group A and group C show divergent cancer phenotypes.
    Melis JP; Wijnhoven SW; Beems RB; Roodbergen M; van den Berg J; Moon H; Friedberg E; van der Horst GT; Hoeijmakers JH; Vijg J; van Steeg H
    Cancer Res; 2008 Mar; 68(5):1347-53. PubMed ID: 18316597
    [TBL] [Abstract][Full Text] [Related]  

  • 30. High incidence of ultraviolet-B-or chemical-carcinogen-induced skin tumours in mice lacking the xeroderma pigmentosum group A gene.
    Nakane H; Takeuchi S; Yuba S; Saijo M; Nakatsu Y; Murai H; Nakatsuru Y; Ishikawa T; Hirota S; Kitamura Y
    Nature; 1995 Sep; 377(6545):165-8. PubMed ID: 7675085
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Alternative models for carcinogenicity testing: weight of evidence evaluations across models.
    Cohen SM
    Toxicol Pathol; 2001; 29 Suppl():183-90. PubMed ID: 11695556
    [TBL] [Abstract][Full Text] [Related]  

  • 32. p53 haploinsufficiency profoundly accelerates the onset of tongue tumors in mice lacking the xeroderma pigmentosum group A gene.
    Ide F; Kitada M; Sakashita H; Kusama K; Tanaka K; Ishikawa T
    Am J Pathol; 2003 Nov; 163(5):1729-33. PubMed ID: 14578172
    [TBL] [Abstract][Full Text] [Related]  

  • 33. DNA repair-deficient Xpa/p53 knockout mice are sensitive to the non-genotoxic carcinogen cyclosporine A: escape of initiated cells from immunosurveillance?
    van Kesteren PC; Beems RB; Luijten M; Robinson J; de Vries A; van Steeg H
    Carcinogenesis; 2009 Mar; 30(3):538-43. PubMed ID: 19136475
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cyclosporin A inhibits nucleotide excision repair via downregulation of the xeroderma pigmentosum group A and G proteins, which is mediated by calcineurin inhibition.
    Kuschal C; Thoms KM; Boeckmann L; Laspe P; Apel A; Schön MP; Emmert S
    Exp Dermatol; 2011 Oct; 20(10):795-9. PubMed ID: 21707758
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Decreased UV sensitivity, mismatch repair activity and abnormal cell cycle checkpoints in skin cancer cell lines derived from UVB-irradiated XPA-deficient mice.
    Ichikawa M; Nakane H; Marra G; Corti C; Jiricny J; Fitch M; Ford JM; Ikejima M; Shimada T; Yoshino M; Takeuchi S; Nakatsu Y; Tanaka K
    Mutat Res; 2000 May; 459(4):285-98. PubMed ID: 10844242
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The relationship between benzo[a]pyrene-induced mutagenesis and carcinogenesis in repair-deficient Cockayne syndrome group B mice.
    Wijnhoven SW; Kool HJ; van Oostrom CT; Beems RB; Mullenders LH; van Zeeland AA; van der Horst GT; Vrieling H; van Steeg H
    Cancer Res; 2000 Oct; 60(20):5681-7. PubMed ID: 11059760
    [TBL] [Abstract][Full Text] [Related]  

  • 37. P53+/- hemizygous knockout mouse: overview of available data.
    Storer RD; French JE; Haseman J; Hajian G; LeGrand EK; Long GG; Mixson LA; Ochoa R; Sagartz JE; Soper KA
    Toxicol Pathol; 2001; 29 Suppl():30-50. PubMed ID: 11695560
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Suppression of UV carcinogenesis by difluoromethylornithine in nucleotide excision repair-deficient Xpa knockout mice.
    Rebel H; van Steeg H; Beems RB; Schouten R; de Gruijl FR; Terleth C
    Cancer Res; 2002 Mar; 62(5):1338-42. PubMed ID: 11888902
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Complementation of the DNA repair deficiency in human xeroderma pigmentosum group a and C cells by recombinant adenovirus-mediated gene transfer.
    Muotri AR; Marchetto MC; Zerbini LF; Libermann TA; Ventura AM; Sarasin A; Menck CF
    Hum Gene Ther; 2002 Oct; 13(15):1833-44. PubMed ID: 12396616
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Xpa knockout mice.
    de Vries A; van Steeg H
    Semin Cancer Biol; 1996 Oct; 7(5):229-40. PubMed ID: 9110400
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.